POMDOCTOR LIMITED most recently reported annual revenue of $400.0M, a net loss of $213.0M. Revenue grew at an average annual rate of 22.7% over the last 5 fiscal years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
POMDOCTOR LIMITED: Revenue rose from $185.0M in 2019 to $400.0M in 2025, a change of +116.2% over 6 years; net profit was positive in 0 of 7 reported years; operating margin moved from -34.6% to -29.1%, a shift of +5.5 percentage points; the most recent year shows a net loss of $213.0M.
Income Statement — 7 Years (USD millions)
Metric
2019
2020
2021
2022
2023
2024
2025
Revenue
$185.0M
$144.0M
$215.0M
$245.0M
$305.0M
$343.0M
$400.0M
Operating Expenses
$249.0M
$390.0M
$295.0M
$249.0M
$327.0M
$368.0M
$516.0M
Operating Profit
$-64.0M
$-246.0M
$-80.0M
$-4.0M
$-22.0M
$-26.0M
$-116.0M
Operating Margin
-34.6%
-170.3%
-37.0%
-1.5%
-7.3%
-7.5%
-29.1%
Other Income
$-9.0M
$-16.0M
$-17.0M
$-16.0M
$-15.0M
$-12.0M
$-15.0M
Interest
$9.0M
$14.0M
$16.0M
$16.0M
$14.0M
$13.0M
$13.0M
Depreciation
$22.0M
$22.0M
$21.0M
$0
$0
$0
$0
Profit Before Tax
$-73.0M
$-262.0M
$-96.0M
$-20.0M
$-37.0M
$-37.0M
$-131.0M
Tax
$0
$0
$0
$0
$0
$0
$0
Net Profit
$-73.0M
$-262.0M
$-188.0M
$-126.0M
$-145.0M
$-143.0M
$-213.0M
EPS
$-11.07
$-39.88
$-28.62
$-19.08
$-22.14
$-21.78
$-3.66
Dividend Payout
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Results — Last 7 Quarters (USD millions)
Metric
Dec '24
Mar '25
Jun '25
Sep '25
Dec '25
Mar '26
Jun '26
Revenue
$96.0M
$87.0M
$87.0M
$113.0M
$113.0M
$93.0M
$27.0M
Operating Expenses
$105.0M
$94.0M
$94.0M
$165.0M
$165.0M
$209.0M
$61.0M
Operating Profit
$-8.0M
$-7.0M
$-7.0M
$-53.0M
$-53.0M
$-117.0M
$-34.0M
Operating Margin
-8.8%
-7.7%
-7.7%
-46.6%
-46.6%
-126.1%
-125.9%
Interest
$0
$0
$0
$0
$0
$0
$1.0M
Profit Before Tax
$-38.0M
$-36.0M
$-36.0M
$-70.0M
$-70.0M
$-119.0M
$-35.0M
Tax
$0
$0
$0
$0
$0
$-30,000
$-30,000
Net Profit
$-38.0M
$-36.0M
$-36.0M
$-70.0M
$-70.0M
$-115.0M
$-34.0M
EPS
$-18.21
$-17.19
$-17.19
$-16.12
$-16.12
$-14.87
$-4.36
Over the 7 years reported for POMDOCTOR LIMITED, borrowings increased from $77.0M in 2019 to $455.0M in 2025, cash stood at $10.0M in the latest year, shareholders' equity was $0, current assets covered current liabilities 0.48 times.
Balance Sheet — 7 Years (USD millions)
Metric
2019
2020
2021
2022
2023
2024
2025
Total Assets
$99.0M
$77.0M
$19.0M
$49.0M
$66.0M
$46.0M
$108.0M
Current Assets
$29.0M
$26.0M
$18.0M
$48.0M
$59.0M
$37.0M
$105.0M
Cash
$11.0M
$13.0M
$2.0M
$2.0M
$7.0M
$8.0M
$10.0M
Inventory
$6.0M
$7.0M
$8.0M
$8.0M
$13.0M
$9.0M
$8.0M
Receivables
$10.0M
$4.0M
$1.0M
$27.0M
$32.0M
$15.0M
$25.0M
Fixed Assets
$14.0M
$13.0M
$0
$0
$1.0M
$0
$1.0M
Capital Work in Progress
$0
$0
$0
$0
$0
$0
$0
Investments
$1.0M
$0
$1.0M
$1.0M
$0
$0
$0
Other Assets
$0
$0
$0
$0
$0
$0
$0
Total Liabilities
$151.0M
$386.0M
$1.8B
$1.9B
$2.0B
$2.1B
$589.0M
Current Liabilities
$113.0M
$329.0M
$109.0M
$144.0M
$172.0M
$179.0M
$218.0M
Borrowings
$77.0M
$114.0M
$341.0M
$361.0M
$413.0M
$441.0M
$455.0M
Other Liabilities
$74.0M
$272.0M
$1.5B
$1.6B
$1.6B
$1.7B
$134.0M
Equity
$0
$0
$0
$0
$0
$0
$0
Reserves
$-52.0M
$-309.0M
$-1.8B
$-2.0B
$-2.1B
$-2.3B
$-454.0M
For POMDOCTOR LIMITED, operating cash flow was positive in 0 of 7 reported years; free cash flow in the latest year was negative at $149.0M; free cash flow was positive in 0 of 7 years; financing activities used $24.0M in the latest year, which covers debt repayment, dividends and buybacks.
POMDOCTOR LIMITED (POM) reported annual revenue of $400.0M in its most recent fiscal year.
What is POMDOCTOR LIMITED's net profit?
POMDOCTOR LIMITED (POM) reported a net loss of $213.0M in its most recent fiscal year.
What is POM EV/EBITDA?
POMDOCTOR LIMITED's enterprise value to EBITDA (EV/EBITDA) ratio is -4.03. A negative value means EBITDA was negative over the period, so the ratio is not a meaningful valuation measure.